Error in Byline - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to the Author Byline and Corresponding Author Name

  • October 30, 2026

Share

  • 1

    A correction applies to the Original Investigation on optimizing trauma-care resources and timely access for patients with severe injuries.

  • 2

    The Original Investigation was published on September 29, 2026.

  • 3

    Kyoungwon Jung’s name was misspelled in the article’s byline.

  • 4

    Kyoungwon Jung’s name was also misspelled in the corresponding-author line.

  • 5

    The correction addresses the misspelling of Kyoungwon Jung’s name in both locations.

Original Source(s)

Error in Byline

  • October 30, 2026

Related Content

FDA expands talazoparib use in prostate cancer

The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .

FDA expands bladder cancer therapy approval

The expansion offers another treatment option for patients with high-grade tumors following BCG failure.

Interpreting Agreement in AI-Assisted American Society of Anesthesiologists (ASA) Classification